Ohlbe
★★★

France,
2020-04-28 23:01
(372 d 01:09 ago)

Posting: # 21358
Views: 2,565
 

 FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe
Activity
 Admin contact
21,444 posts in 4,482 threads, 1,509 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Thursday 00:10 CEST (Europe/Vienna)

In matters of style, swim with the current;
in matters of principle, stand like a rock.    Thomas Jefferson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5